Treatment with Neuraminidase inhibitors (e.g. zanamivir, oseltamivir). 6 studies conducted, with 2,356 children. Shortens the duration of the Flu symptoms by 1 day on average, and may reduce ear infections. Impact on other complications remains unclear. Mild side effects, including vomiting.
Consider this treatment for children with Flu:
It may shorten the duration of the Flu symptoms a bit and prevent ear infections, but it evokes vomiting.
Works best if taken within 2 days of having flu symptoms, and should be taken for 5 consecutive days.
For example: Oseltamivir (Tamiflu), Zanamivir (Relenza)
Children with Flu, 2 to 16 years old
Varies according to age, weight and treatment. Oseltamivir usually 2 mg/kg, twice-daily, for 5 days. Zanamivir usually 10 mg, twice-daily, for 5 days.
Treatment of Influenza infection, symptoms and complications
Shortened the duration of Flu symptoms by about one day. May reduce ear infections based on only one trial. Unclear impact on other complications.
Common side effects include vomiting, diarrhea, nausea, headache, nosebleeds and trouble sleeping. Rare side effects may include psychiatric symptoms, trouble breathing and seizures.
Flu (influenza virus infection and symptoms).
Symptoms and signs:
Cough, dizziness, fever, headache, nausea, pains, runny nose, sore throat, vomiting and aches.
Ear infection, lung infection, Seizures.
Visitors at this page also visited
Neuraminidase inhibitors (NAIs) are a class of drugs which block the neuraminidase enzyme. They are commonly used as antiviral drugs because they block the function of viral neuraminidases of the influenza virus, by preventing its reproduction by budding from the host cell. Oseltamivir (Tamiflu) a prodrug, Zanamivir (Relenza), Laninamivir (Inavir), and Peramivir belong to this class. (source)
Similar pages on this site
Good to know
Battling bad science
Ben Goldacre, science journalist
Don't gamble on your health!
Look for concrete evidence BEFORE you undergo any procedure!
When Evidence Says No, but Doctors Say Yes - An Epidemic of Unnecessary Treatment
David Epstein and Propublica, The Atlantic